Yixintang Pharmaceutical (SZ:002727)2024-11-01 11:17Group 1: Investor Relations Activity Overview - The investor relations activity was a performance exchange meeting for the Q3 2024 report held on October 31, 2024 [1] - The meeting took place at the headquarters of Yixin Tang Pharmaceutical Group Co., Ltd. from 15:00 to 16:30 [1] - Key company representatives included Zhang Yong (CEO), Li Zhenghong (Vice President), and Xiao Donglei (Financial Officer) [1] Group 2: Participants and Attendance - A total of 88 investors participated in the meeting, including representatives from various securities firms [1] - Notable participants included Zheng Wei and Fu Pengfei from Guolian Securities, and Zhu Guoguang from Dongwu Securities [2] - The list of attendees also featured representatives from major firms such as Morgan Stanley, UBSK, and Haitong International Securities [2][3] Group 3: Meeting Content and Focus - The primary focus of the meeting was to discuss the Q3 2024 financial performance and engage with investors [1] - The meeting included a detailed analysis of the company's financial results and future outlook [1] - Additional materials provided included records of investor research meetings [1]